NASDAQ Markets
· Mar 26, 2025 6:19 AM EDT
Not market news
FDA Grants Fast Track Designation To Sanofi's MRNA Vaccine Candidate For Chlamydia Prevention
(RTTNews) - Sanofi (SNYNF, SNY) announced Wednesday that the US Food and Drug Administration has granted fast track designation to the company's mRNA vaccine candidate for the prevention of chlamydia infection.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
- Who's exposed
- SNYSanofi Named
Companies named in the story.
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the briefHow this story developed
2 reports over 23h 56m-
NASDAQ Markets Sanofi's Tolebrutinib Under FDA Priority Review For Treating NrSPMS & Slowing Disability Progression Bearish −31
-
NASDAQ Markets You're reading this FDA Grants Fast Track Designation To Sanofi's MRNA Vaccine Candidate For Chlamydia Prevention

